CCP
Clough Capital Partners Portfolio holdings
AUM
$997M
This Quarter Return
-2.45%
1 Year Return
+37.42%
3 Year Return
+130.83%
5 Year Return
+251.5%
10 Year Return
+1,002%
AUM
$2.12B
AUM Growth
+$2.12B
(-0.63%)
Cap. Flow
+$124M
Cap. Flow
% of AUM
5.83%
Top 10 Holdings %
Top 10 Hldgs %
24.7%
Holding
271
New
78
Increased
60
Reduced
61
Closed
62
Top Buys
| 1 |
Energy Select Sector SPDR Fund
XLE
|
$53M |
| 2 |
BP
BP
|
$44.7M |
| 3 |
AGNC Investment
AGNC
|
$32.7M |
| 4 |
HES
Hess
HES
|
$24.7M |
| 5 |
Ares Capital
ARCC
|
$22M |
Top Sells
| 1 |
Starbucks
SBUX
|
$33.2M |
| 2 |
CPN
Calpine Corporation
CPN
|
$32.2M |
| 3 |
Eversource Energy
ES
|
$31.9M |
| 4 |
AT&T
T
|
$28.1M |
| 5 |
GRA
W.R. Grace & Co.
GRA
|
$26.8M |
Sector Composition
| 1 | Consumer Discretionary | 18.4% |
| 2 | Communication Services | 15.41% |
| 3 | Financials | 15.11% |
| 4 | Healthcare | 11.25% |
| 5 | Technology | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Jazz Pharmaceuticals
JAZZ
$7.96B
| $5.66M | 0.27% |
43,331
-45,683
| -51% | -$5.96M |
|
|
ITCI
102
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.56M | 0.26% |
200,050
-8,550
| -4% | -$238K |
|
103
AstraZeneca
AZN
$252B
| $5.41M | 0.26% |
192,218
-213,285
| -53% | -$6.01M |
|
|
GCP
104
DELISTED
GCP Applied Technologies Inc.
GCP
| $5.29M | 0.25% |
+265,100
| New | +$5.29M |
|
105
Precigen
PGEN
$1.53B
| $5.16M | 0.24% |
152,203
-288,287
| -65% | -$9.77M |
|
106
Wave Life Sciences
WVE
$1.22B
| $5.13M | 0.24% |
373,150
-19,800
| -5% | -$272K |
|
107
Veracyte
VCYT
$2.39B
| $4.95M | 0.23% |
917,289
-144,065
| -14% | -$778K |
|
|
FRSH
108
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $4.95M | 0.23% |
414,121
+68,600
| +20% | +$820K |
|
109
Cigna
CI
$79.7B
| $4.78M | 0.23% |
34,850
-84,136
| -71% | -$11.5M |
|
|
OTIC
110
DELISTED
Otonomy, Inc.
OTIC
| $4.72M | 0.22% |
316,503
+36,100
| +13% | +$539K |
|
|
ALXN
111
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.5M | 0.21% |
+32,350
| New | +$4.5M |
|
|
CLLS
112
Cellectis
CLLS
$258M
| $4.43M | 0.21% |
160,950
-47,150
| -23% | -$1.3M |
|
113
MACOM Technology Solutions
MTSI
$9.69B
| $4.33M | 0.2% |
98,900
+17,100
| +21% | +$749K |
|
114
Kura Oncology
KURA
$713M
| $4.32M | 0.2% |
1,067,133
-20,100
| -2% | -$81.4K |
|
115
ON Semiconductor
ON
$20B
| $4.16M | 0.2% |
+433,500
| New | +$4.16M |
|
|
KERX
116
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $4.06M | 0.19% |
870,200
-832,900
| -49% | -$3.89M |
|
|
TMH
117
DELISTED
Team Health Holdings Inc
TMH
| $4.06M | 0.19% |
97,037
-49,063
| -34% | -$2.05M |
|
118
Invesco DB US Dollar Index Bullish Fund
UUP
$175M
| $3.99M | 0.19% |
162,600
-115,804
| -42% | -$2.84M |
|
|
KDNY
119
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.82M | 0.18% |
298,137
+40,300
| +16% | +$516K |
|
120
Becton Dickinson
BDX
$53.1B
| $3.42M | 0.16% |
+22,525
| New | +$3.42M |
|
121
Edwards Lifesciences
EW
$47.8B
| $3.37M | 0.16% |
+38,200
| New | +$3.37M |
|
122
Medtronic
MDT
$119B
| $3.32M | 0.16% |
+44,300
| New | +$3.32M |
|
123
Boston Scientific
BSX
$159B
| $3.31M | 0.16% |
+175,950
| New | +$3.31M |
|
|
RSX
124
DELISTED
VanEck Russia ETF
RSX
| $3.22M | 0.15% |
+197,004
| New | +$3.22M |
|
125
NMI Holdings
NMIH
$3.04B
| $2.89M | 0.14% |
573,100
-13,900
| -2% | -$70.2K |
|